loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 204984 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ACETAMINOPHEN; BUTALBITAL; CAFFEINE (1)

filter

01 ALVOGEN (1)

filter

01 TABLET;ORAL (1)

filter

01 325MG;50MG;40MG (1)

filter

01 USA (1)

URL Supplier Web Content
TABLET;ORAL
325MG;50MG;40MG
BUTALBITAL, ACETAMINOP...
USA
204984
2017-01-10
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 204984

Looking for CTD TGA MCC DOSSIER APPLICATION 204984 1

19

Alvogen, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ACETAMINOPHEN; BUTALBITAL; CAFFEINE, with a corresponding application number 204984 and regulatory information .

proudly manufactured in the

approval since 2017-01-10

Alvogen's BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET;ORAL, medication with 325MG;50MG;40MG of ACETAMINOPHEN; BUTALBITAL; CAFFEINE.

Post Enquiry
POST ENQUIRY